Chery’s robot affiliate AiMOGA eyes IPO, targets overseas market

AiMOGA Robotics (Chery’s robotics affiliate) is preparing for a potential IPO, seeking funds to accelerate humanoid robot investments, as competition intensifies in China’s sector. The company has delivered 3,000 robots globally (2,000 overseas) and targets 10,000 deliveries next year, after already deploying 110 humanoid police robots across Chinese cities for traffic management and public-safety use. Investor enthusiasm is rising as Unitree nearly six-folded in its Shanghai debut, while AiMOGA’s listing prospects are still unconfirmed on timing or venue.

Analysis

This is more a capital-markets signal than a fundamental step-change: a wave of robotics listings can temporarily re-rate the entire China automation complex, but it also creates a larger supply of paper chasing the same early-stage narrative. The first-order winners are exchange/underwriting ecosystems and adjacent component suppliers; the second-order winners are the incumbents with real industrial cash flow, because retail/speculative capital tends to rotate out of them once the new issue pipeline deepens.

The key risk is that the market conflates addressable market size with monetizable demand. Humanoid robotics is still a long-duration adoption story; if unit growth is driven by public-sector demos and showroom deployments, near-term revenue visibility will stay thin while R&D and SG&A scale faster than gross profit. That makes valuation especially fragile in a 1-3 month window if the IPO pricing is aggressive or if the next batch of listings competes for the same capital.

Contrarian read: consensus is likely underestimating how much dilution the sector needs before it can fund commercialization, and overestimating how quickly policy-backed use cases convert into repeatable enterprise spend. The real falsifier is not another headline about deliveries; it is evidence of durable margins and contracted demand. If any listed name can show meaningful recurring revenue, municipal/enterprise renewals, and improving unit economics over the next 6-18 months, then the current skepticism becomes the wrong side of the trade.

Key Decisions for Investors

• Do not chase the first wave of China humanoid-robotics IPOs; wait for pricing terms and lockup structure before underwriting the risk/reward.
• Use a 1-3 month fade on robotics/theme baskets such as BOTZ or ROBO if they gap on listing headlines; the trade works if inflows outrun fundamentals, with a stop if the basket holds gains after the first post-IPO supply cycle.
• Prefer quality automation over story stocks: long ABB or ROK versus short a China robotics/theme basket on a 3-6 month horizon, betting that cash-flowing incumbents re-rate less but earn through the cycle.
• Set an alert for any proposed IPO pricing above ~10x forward sales or >3x the implied valuation of industrial automation peers; above that level, the market is paying for option value, not earnings, and post-listing downside risk rises sharply.
• If you want exposure, keep it indirect via broad China tech/industrial proxies rather than private-name enthusiasm until there is evidence of recurring revenue and margin leverage.